Infectious Diseases

August 15, 2022
ROCHESTER, Minn. — Mayo Clinic researchers say the monoclonal antibody bebtelovimab, already authorized by the Food and Drug Administration for emergency use on the omicron[...]

October 6, 2016

October 4, 2016

October 3, 2016

September 29, 2016

September 29, 2016

September 26, 2016

September 22, 2016

September 20, 2016

September 19, 2016

September 15, 2016

September 12, 2016

September 8, 2016
Explore more topics
Sign up

Mayo Clinic Connect
An online patient support community